Open Accessibility Menu

DaTscanTM (Ioflupane I123 injection) Now Available at Good Samaritan

DaTscanTM (Ioflupane I123 injection) Now Available at Good Samaritan

Good Samaritan is pleased to offer GE HealthCare’s DaTscan, an adjunct to other diagnostic evaluations for striatal dopamine transporter visualization using single photon emission computer tomography (SPECT) brain imaging in adult patients with suspected Parkinsonian syndromes (PS) or suspected dementia with Lewy bodies (DLB).

The clinical signs and symptoms of DLB can be atypical and overlap with other forms of dementia, leading to up to 70% of patients with DLB being misdiagnosed, often as having Alzheimer’s Disease. This new indication enables clinicians to use DaTscan to help differentiate DLB from other forms of dementia. Early and accurate diagnosis of DLB can help ensure specific appropriate treatment and specialized care for patients, while enabling them and their caregivers to more effectively manage the disease and plan for the future.

The availability of DaTscan at Good Samaritan provides local physicians with a proven diagnostic tool that supports clinical evaluation and diagnostic confidence when examining patients who are impacted by movement disorders and symptoms related to DLB.

“DaTscan is a great tool,” stated Brook Strahle, Good Samaritan Nuclear Medicine Technician. “This imaging gives doctors information to guide treatment and select the best medications for their patients with suspected Parkinsonian syndromes or Dementia with Lewy Bodies. We're proud to offer it here, and we're proud to support the mission of the hospital to care for the people in this region with quality testing.”